6/22/2023 0 Comments Kite pharma stock priceDid you use Conf Meter at all? What else did you consider? FDA data and dates have been available for a while so if you particularly like pharma companies and look at FDA alerts, that’s probably pretty useful too. So then, some of our users who hopefully got into $KITE back in June – hopefully other investors (and we) can learn more your investing decisions. What’s also interesting to note is that the Confidence Meter for KITE has stayed above 60% all along since that time. If the nerd in you wants to dig into the Confidence Meter a little bit more, head here. Also, even though there weren’t many new analyst reports in the last couple of months, the algo kept working the value of Confidence Meter because the stock price was moving and therefore each available analyst opinion was becoming ‘more right’ or ‘more wrong’ every day. So while there might have been analysts moderately bullish or sorta bearish or highly bullish about KITE back in June, Stockal’s algo would have figured out what it actually meant for the investor and created a unified Confidence Meter automatically. Stockal’s algorithm parses through dozens of (often seemingly diverse) analyst opinions for a stock at any given point of time and “weighs” each opinion by the historic performance of the analyst “for that stock”. Confidence Meter is a reflection of the overall Wall Street analyst opinion for any stock. Well, not the acquisition, but certainly the bullishness. Now, in way you can say that the analysts called it. We thought this might be a good time to show what the data on Stockal said around the middle of June. To say the least!Ĭonfidence Meter KITE Pharma: Stock Price vs Confidence Meter Recent news of the Kite Pharma ( NASDAQ: KITE) acquisition by Gilead Sciences ( NASDAQ: GILD) for close to $12 billion and the general rise of the KITE stock even prior to the acquisition – from $87.8 in mid-June all the way to over $179 yesterday – has been thrilling to watch. It’s always incredible for a company developing a new innovation in an existing field when its tech yields satisfying results.
0 Comments
Leave a Reply. |